Test Code LABFDISP Disaccharidase Activity Panel, Tissue
Additional Codes
Test Name in EPIC | EPIC Test Code | Mnemonic | Mayo Test ID |
DISACCHARIDASE PANEL | LABFDISP | DSAC | DSAC |
Shipping Instructions
Freeze immediately after collection and ship frozen.
Specimen Required
Source: Intestinal biopsy
Supplies: 15 mL Tissue Tube-DSAC (T993)
Container/Tube: 15 mL tissue tube
Specimen Volume: 5 mg
Collection Instructions:
1. Place specimen in tissue tube.
2. Specimen should not be placed on gauze, filter paper, or swabs/wooden sticks and should not have any saline, water, support, or embedding material added.
Forms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
Useful For
Evaluation of patients who present with signs or symptoms suggestive of disaccharidase disorders
This test is not intended for carrier detection.
Genetics Test Information
Diagnostic testing for patients with clinical signs and symptoms suspicious of a disaccharidase deficiency.
Method Name
Spectrophotometry
Reporting Name
Disaccharidase Activity Panel, TsSpecimen Type
TissueSpecimen Minimum Volume
See Specimen Required
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Tissue | Frozen | 28 days |
Reject Due To
Specimens sent in formaldehyde, saline, or any supportive media Specimens placed on gauze, filter paper, foil, or swabs/wooden sticks |
Reject |
Clinical Information
Disaccharidases in the small intestines are responsible for the breakdown of disaccharides (double sugars) into monosaccharides (simple sugars). Patients with a deficiency of one or more disaccharidase can experience intolerance to foods containing complex sugars resulting in a range of gastrointestinal symptoms, including diarrhea or constipation, abdominal pain and cramping, gas, bloating, and nausea. In addition, patients may experience malnutrition, weight loss, or failure to thrive. Given the nonspecificity and frequency of abdominal symptoms, misdiagnosis or a diagnostic delay of disaccharide deficiencies may occur.
Primary and secondary causes of disaccharidase deficiencies exist, and age of onset may vary from birth through adulthood. Primary causes are rare and result from genetic alterations in a variety of genes. Secondary deficiencies typically result from small intestinal mucosal damage. Treatment of both primary and secondary disaccharidase deficiencies involves dietary management. While primary deficiencies require lifelong treatment, secondary disaccharidase deficiencies may require treatment only until the intestinal lining recovers.
Reference Values
Lactase: ≥14.0 nmol/min/mg protein
Sucrase: ≥19.0 nmol/min/mg protein
Maltase: ≥70.0 nmol/min/mg protein
Palatinase: ≥6.0 nmol/min/mg protein
Glucoamylase: ≥8.0 nmol/min/mg protein
Interpretation
Quantitative values of lactase, sucrase, maltase, palatinase, and glucoamylase are reported. Clinical interpretation of results is provided.
Cautions
This test will not distinguish between primary and secondary causes of disaccharidase deficiencies.
Method Description
Disaccharidase activities are measured by incubating intestinal homogenates with an appropriate disaccharide substrate, which releases glucose. Glucose production is determined by a glucose oxidase reagent mixture that oxidizes glucose to produce peroxide, which reacts with phenol aminophenazone to form a red quinoneimine dye. The concentration of quinoneimine is determined spectrophotometrically, and the concentration of liberated glucose is calculated from a glucose standard curve. The amount of glucose produced is proportional to the disaccharidase activity in the intestinal homogenate. Disaccharidase activities are expressed as nanomoles of glucose per minute per milligram of protein (nmol/min/mg prot).(Unpublished Mayo method)
Day(s) Performed
Monday through Friday
Report Available
3 to 4 daysSpecimen Retention Time
Biopsy homogenate: 1 monthPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82657
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
DSAC | Disaccharidase Activity Panel, Ts | 57765-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
608237 | Lactase | 81315-4 |
608238 | Sucrase | 30372-7 |
608239 | Maltase | 30315-6 |
608240 | Palatinase | 81314-7 |
608241 | Glucoamylase | 81322-0 |
608242 | Interpretation | 57779-1 |
608243 | Reviewed By | 18771-6 |